{"name":"Nordic Bioscience A/S","slug":"nordic-bioscience-a-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SMC021 Oral Calcitonin","genericName":"SMC021 Oral Calcitonin","slug":"smc021-oral-calcitonin","indication":"Treatment of hypercalcemia of malignancy","status":"phase_3"}]}],"pipeline":[{"name":"SMC021 Oral Calcitonin","genericName":"SMC021 Oral Calcitonin","slug":"smc021-oral-calcitonin","phase":"phase_3","mechanism":"SMC021 Oral Calcitonin works by mimicking the action of the naturally occurring hormone calcitonin to lower blood calcium levels.","indications":["Treatment of hypercalcemia of malignancy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNRmhvVlpTTXp2SGE1eGJZcXdCSVRIT3Z6ZW9FeFRGZmp2cEI4VzV2cHhhc3ZhaWQ3S2tST3JGLU54MXJTR0FEU1BKbzhuR20zMEpFRGEzU29RV21hNk9FMlo0clhXTTR0X1B5SjI3el8xbEMxY2xheVozdF9FNkZ0YXMzMWFkZUV4Nlc0Z0xLc3N5UmdfVjNjNEpMdGw?oc=5","date":"2025-07-02","type":"pipeline","source":"FNIH","summary":"Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Stage 2.0 - FNIH","headline":"Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Stage 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQblJteHV3aHBGYnM1RVZaSWFhWmJkV0g3MUdHWFpvUWV5VEMxZGI2bHFBTjNMQ29KbTZseVJZNUhzUHRLbVZEdGYxeHBsQmZiSmFLWm1ZZ0dVLVR6dUpOc0V6ZGZBYzZ3NDZWWlloUFozYk9WUUF2bEtlWldOMUc0MWQ3Ui1DQkpTUWJnS1VKQ0JyV0VhM0k1Z3o3dV8tU0xfRU1PcEUzd2IyT0x1U1Z1OFF4WW4tZlo4U2xBeDlCMk5Ec0thN182UC1IQXpCV09BT1E?oc=5","date":"2025-05-08","type":"pipeline","source":"Newswire Canada","summary":"Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers - Newswire Canada","headline":"Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNV2NCNXRLOWdhS2dkeGtyRFplMzRydkJJcDFwYTVOTldzM25YcXh2X2EwOWZrRkNJNDY0aDJqVEEzSnZGYnV4UTBHRVhYUDIzOFRUUW9zeERsdjhSWFk5b1Brdll6cXF1ZkZuNE1KRHlFMGZXZURoU2plZXFJS3BUaVF5WmZyT0otMVliNUIyVzNQWnkwaG9Gek1Jb2NHeDAwX1F2c2FUXzBRVjNkVTEwVHpRQWd3eGpaaEVYWXVlSi1jMjZzaU9pQmtjekdyZzlXYXlsRHg3cDRwWHQtdjBseVVxTzcwcGxjaVcxc0x6UDRuNGZVUXpPM3Z1cUk3YTdySlFnaHNTSmxtOEhoUWs4Wkd6Q0dDUXUzTGF3a25rdVl1M3M?oc=5","date":"2024-02-06","type":"earnings","source":"PR Newswire UK","summary":"Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024. - PR Newswire UK","headline":"Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQZ1hwUzJnOXRnNE01QXNCY2x0amEyc1BSdkJVUFNkU296MXJ6M2ktMlQtLWI0Q1U4c1JWTW9aR2oxaXFrOHVlUnVQenNfZm9aQXEzeFFVRlpLRUdKTkU0dWl2NEVRT2g5ZDgzWnYzYkZ2Q3RUci02S3JZdXNlMkdvWmNCZlpad2xwUG1NTUI5Q3VNSXh0a3B4NHpnZzdkRzNPbm4taEgyT1FjU3owYmJvcFBsaE9ra1I1R0ZnWEdSaFczRXRrSEg4RG43MldlYk5Q?oc=5","date":"2023-07-28","type":"regulatory","source":"BioWorld News","summary":"KBP-336 shows antiobesity efficacy in treatment sequencing and in combination with semaglutide - BioWorld News","headline":"KBP-336 shows antiobesity efficacy in treatment sequencing and in combination with semaglutide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxORF93SFJMX0NyT3lIV0pDTmNOak4zU2QtMXhka3AxQl9vbjVTZzF1T0d0SFRCMG02Rl9JNzZpQTZ4M3BTSmhqTzZ0ZTVKdlljRDlUTExKRno4eUpkYnFWSGtGRVlsZmRaM0k3NlJxSnMzT2VPWlViVENrdDItOUxwa01uTDZVUnBEMFVwbDRaN3BUbU0?oc=5","date":"2021-06-28","type":"pipeline","source":"EU-Startups","summary":"77 Top Biotechnology Startups and Companies in Denmark (2021) - EU-Startups","headline":"77 Top Biotechnology Startups and Companies in Denmark (2021) - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNcV9rc1NNWFdYakZIRFB3NzFYeDE3LTR3UU16cF9lSGZZTzlaczZDbEY3dmFVTG5Hem9wUFZWZ1daRmdqUGI2U0tmUUYza2l2NGZ6eXFDOG1xczNwVnMwNzdNb1EwZ3pUT21hTmlyUkxJbjhmNlRTbElMQWdWWVZtcnlIaTJyazlvb0VJNEhtNXpseE9xc0hLcjRGVEI3aExUOWZxRXNfM3pXWmRkZ05zTFVR?oc=5","date":"2021-03-23","type":"deal","source":"Bloomberg.com","summary":"Nordic Capital Buys Stake in $3.6 Billion Drugmaker Leo Pharma - Bloomberg.com","headline":"Nordic Capital Buys Stake in $3.6 Billion Drugmaker Leo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNSm1pUk8wajEwSmtKcGd0aDFGcF9XMzFBaGg1ZGFhT243S2RqRXFHX1hzX3QybkhSZHNmdTVPOGR3SjFZVDM0NnFDUzAzQ0V4UUtWR0VzOVhGSTd1VEh2cFRQaW93MU9XdFRJaVI0TGlTV3RnMEMwUWllNjk0NmdlcU80UHRLaFJqSFNUZklKdDZjbjVacm5JVHFrb0lhRHU4Y1RzNDRzejREWFZjcUswTWpwVVhNb2Zlb3JrdFQ1UXlaUGg2ZzVrZmdTVHp4Z0swdVAwcnY1SkM5YmhhV2c?oc=5","date":"2020-03-11","type":"pipeline","source":"Novo Nordisk Fonden","summary":"Aarhus University and the pharmaceutical industry join forces on open innovation – a pathway to new medicines - Novo Nordisk Fonden","headline":"Aarhus University and the pharmaceutical industry join forces on open innovation – a pathway to new medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNT2RBcnk2bmJZZGpUWTRlR0JFcjNZekRYUUFaajV2SHhMQkNSdGtmZzZFQkYwYWxTOV9GY2lXN0JsZzI3UkZXMWtKalNqNXF0Nl9NVVBpQ2VlcExQYlRvV0dHTERtZVBPbmo4dlBESC1aQ1ZjbElxX2ZoUVFYYU9DcDVrNDVSSzVTellr?oc=5","date":"2018-04-04","type":"pipeline","source":"BioPharma Dive","summary":"Lilly’s next diabetes play would have patients implanted with engineered stem cells - BioPharma Dive","headline":"Lilly’s next diabetes play would have patients implanted with engineered stem cells","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}